General MedicationsINTRAVENOUSStandard

LEVOLEUCOVORIN CALCIUM

Standard Dose

EQ 250MG BASE/25ML (EQ 10MG BASE/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview LEVOLEUCOVORIN CALCIUM is listed in Drugs@FDA under application 217314 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOLEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAVENOUS - EQ 250MG BASE/25ML (EQ 10MG BASE/ML) Sponsor HAINAN POLY PHARM Submission history Latest submission status date: 2023-05-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOLEUCOVORIN CALCIUM is listed in Drugs@FDA under application 217314 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOLEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAVENOUS - EQ 250MG BASE/25ML (EQ 10MG BASE/ML) Sponsor HAINAN POLY PHARM Submission history Latest submission status date: 2023-05-22 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.